What Are Medical Tests?

Medical tests are procedures performed on patients or biological samples to detect, diagnose, monitor, or screen for health conditions. They provide objective data that support clinical decision-making, ranging from a simple blood glucose measurement at the bedside to a whole-genome sequencing panel used to identify hereditary disease variants. Medical tests are evaluated along dimensions that include diagnostic accuracy, reproducibility, patient burden, turnaround time, and cost, with the balance among these factors determining where and how a test is used in clinical practice.

The technical evaluation of any medical test centers on two complementary accuracy metrics: sensitivity (the probability that the test is positive when the condition is present) and specificity (the probability that the test is negative when the condition is absent). As defined in the NCBI StatPearls chapter on diagnostic testing accuracy, these metrics underpin the selection of decision thresholds and the calculation of predictive values that depend on the disease prevalence in the tested population. Receiver operating characteristic (ROC) analysis summarizes the trade-off between sensitivity and specificity across all possible thresholds, and the area under the ROC curve is a standard summary statistic for comparing test performance.

Diagnostic Testing Principles

Every medical test involves a measurement and a decision rule: the test value is compared to a threshold or reference range, and the result guides whether a condition is considered present, absent, or uncertain. The choice of threshold involves an explicit trade-off between false positives and false negatives, and this trade-off is made differently depending on the clinical stakes. For a test used to screen for a treatable, serious disease, a lower threshold (higher sensitivity) is preferable even at the cost of more false positives that require confirmatory testing. The CDC laboratory diagnostic sensitivity and specificity guidance describes how clinical laboratory professionals select decision thresholds to optimize the operating characteristics for each testing context. Pre-analytical variables, including sample collection, handling, and storage, can substantially affect test accuracy independent of the analytical method.

Imaging-Based Tests

Imaging tests generate visual representations of internal anatomy or physiology using diverse physical principles: X-ray attenuation (radiography, CT), acoustic reflection (ultrasound), nuclear magnetic resonance (MRI), or radiotracer emission (PET, SPECT). Mammography, the primary screening method for breast cancer, uses low-dose X-ray to image breast tissue and detects microcalcifications, masses, and architectural distortions associated with malignancy. Digital mammography and tomosynthesis (3D mammography) have improved sensitivity over conventional film, with IEEE Spectrum coverage of breast cancer detection advances describing how AI-assisted analysis further reduces both missed cancers and false-positive recall rates. Computer-aided detection systems trained on large annotated datasets now function as a second reader in screening programs, flagging candidate lesions for radiologist review.

Laboratory and Molecular Tests

Laboratory tests analyze blood, urine, tissue, or other biological specimens using biochemical, microbiological, immunological, or molecular methods. Complete blood counts, metabolic panels, coagulation studies, and cultures are mainstays of clinical chemistry and microbiology. Molecular diagnostic tests detect nucleic acid sequences specific to pathogens or genetic variants, enabling rapid identification of infectious agents and inherited conditions with high specificity. Point-of-care testing brings laboratory-equivalent measurements to the bedside or community setting using compact, self-contained analyzers, a capability that proved critical during the COVID-19 pandemic for rapid SARS-CoV-2 antigen and nucleic acid testing.

Applications

Medical tests have applications across the full range of clinical and public health activities, including:

• Cancer screening programs using mammography, colonoscopy, and PSA measurement
• Infectious disease diagnosis and surveillance through culture, serology, and molecular assays
• Cardiovascular risk assessment via lipid panels, troponin, and electrocardiography
• Genetic and genomic testing for inherited disease risk and pharmacogenomics
• Therapeutic drug monitoring in patients on anticoagulants, immunosuppressants, or anticonvulsants
• Population-level epidemiological surveys estimating disease prevalence and burden